EPAM Systems (EPAM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with virtual participation and voting options for shareholders.
2025 performance marked by strong growth in AI-native services, double-digit sequential revenue increases, and continued investment in AI capabilities.
Leadership transition executed, with Balazs Fejes appointed CEO and Arkadiy Dobkin as Executive Chair in September 2025.
Board and management confident in accelerated revenue growth and improved profitability, supported by innovation and strategic investments.
Voting matters and shareholder proposals
Election of four Class II directors for one-year terms.
Approval sought for a charter amendment granting shareholders with 25% ownership the right to call special meetings; Board recommends FOR.
Ratification of Deloitte & Touche LLP as independent auditor for 2026.
Advisory vote on executive compensation (say-on-pay); Board recommends FOR.
Amendments to increase shares available under the 2025 Long Term Incentive Plan (+4,000,000 shares) and 2021 Employee Stock Purchase Plan (+650,000 shares); Board recommends FOR.
Advisory vote on a shareholder proposal to allow 10% ownership to call special meetings; Board recommends AGAINST, citing preference for 25% threshold.
Board of directors and corporate governance
Board consists of 11 members, with phased declassification to annual elections by 2028.
Nine of 11 directors are independent; all committees are composed solely of independent directors.
Board diversity includes 36% female directors and members born outside the US; average tenure is 10.5 years.
Lead Independent Director role established and re-elected annually.
Succession planning is a regular agenda item, with recent CEO transition highlighted.
Stockholder engagement program expanded, with outreach to over 45 stockholders representing 25% of shares.
Latest events from EPAM Systems
- Annual meeting covers director elections, auditor ratification, and key shareholder rights proposals.EPAM
Proxy filing6 Apr 2026 - Shareholders will vote on director elections, equity plan amendments, and expanded governance rights.EPAM
Proxy filing26 Mar 2026 - Accelerating as an AI-native leader, targeting 16%+ margins and $1.8B+ free cash flow by 2028.EPAM
Investor Day 202612 Mar 2026 - Strong 2025 growth and AI momentum support a robust 2026 outlook for revenue and EPS.EPAM
Q4 202519 Feb 2026 - Q2 revenue down 2% YoY; healthcare strong, margins lower, new $500M buyback approved.EPAM
Q2 20242 Feb 2026 - Q3 revenue and EPS rose, NEORIS acquisition expanded reach, and share buybacks accelerated.EPAM
Q3 202416 Jan 2026 - Q4 2024 delivered strong growth and 2025 guidance targets double-digit revenue gains.EPAM
Q4 202413 Dec 2025 - Board declassification, majority voting, and new incentive plan headline 2025 proxy.EPAM
Proxy Filing1 Dec 2025 - Proxy seeks approval for board declassification, majority voting, and new long-term incentive plan.EPAM
Proxy Filing1 Dec 2025